To study the effect of Pradarahara Kasaya And Pathyamalakyadi Kasaya In Excessive Menstrual Bleeding

An Open Labelled Randomised Comparative Clinical Study On The Effect Of Pradarahara Kasaya And Pathyamalakyadi Kasaya In The Management Of Asrigdara W.S.R To Dysfunctional Uterine Bleeding - Asrigdara (D.U.B)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/030961

Enrollment

Registered

2021-02-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle

Interventions

Intervention1: Pradarahara Kasaya: 48 ml BD for 60 days Control Intervention1: Pathyamalakyadi Kasaya: 48 ml BD for 60 days

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling the diagnostic criteria Patients diagnosed as DUB Both married and unmarried women Patients ready to sign the informed consent form

Exclusion criteria

Exclusion criteria: Patients with systemic disorders Patients with IUCD and patients taking OCPs Patients with uterine and pelvic pathology Benign and malignant growth in uterus Endometrial and endocervical polyp Threatened, spontaneous or incomplete abortion Patients having Hb % less than 8 grams

Design outcomes

Primary

Measure	Time frame
Beneficial for irregular, prolonged and heavy mensesTimepoint: 35 days	—

Secondary

Measure	Time frame
Also reduce symptoms like angamarda, daurbalya, bhrama, aruchi, daha, trusha etcTimepoint: 15 days	—

Countries

India

Contacts

Public ContactDr Rita B Makim

Parul University

ritamakim@gmail.com7990727524

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026